These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18607526)

  • 21. Open-channel blockade is less effective on GluN3B than GluN3A subunit-containing NMDA receptors.
    McClymont DW; Harris J; Mellor IR
    Eur J Pharmacol; 2012 Jul; 686(1-3):22-31. PubMed ID: 22564863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Budipine is a low affinity, N-methyl-D-aspartate receptor antagonist: patch clamp studies in cultured striatal, hippocampal, cortical and superior colliculus neurones.
    Parsons CG; Hartmann S; Spielmanns P
    Neuropharmacology; 1998 Jun; 37(6):719-27. PubMed ID: 9707285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Memantine binding to a superficial site on NMDA receptors contributes to partial trapping.
    Kotermanski SE; Wood JT; Johnson JW
    J Physiol; 2009 Oct; 587(Pt 19):4589-604. PubMed ID: 19687120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trapping channel block of NMDA-activated responses by amantadine and memantine.
    Blanpied TA; Boeckman FA; Aizenman E; Johnson JW
    J Neurophysiol; 1997 Jan; 77(1):309-23. PubMed ID: 9120573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Voltage-dependent inhibition of recombinant NMDA receptor-mediated currents by 5-hydroxytryptamine.
    Kloda A; Adams DJ
    Br J Pharmacol; 2005 Feb; 144(3):323-30. PubMed ID: 15655527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel class of amino-alkylcyclohexanes as uncompetitive, fast, voltage-dependent, N-methyl-D-aspartate (NMDA) receptor antagonists--in vitro characterization.
    Gilling K; Jatzke C; Wollenburg C; Vanejevs M; Kauss V; Jirgensons A; Parsons CG
    J Neural Transm (Vienna); 2007; 114(12):1529-37. PubMed ID: 17728997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
    Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
    Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro galantamine-memantine co-application: mechanism of beneficial action.
    Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
    Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of memantine and amantadine with agonist-unbound NMDA-receptor channels in acutely isolated rat hippocampal neurons.
    Sobolevsky AI; Koshelev SG; Khodorov BI
    J Physiol; 1998 Oct; 512 ( Pt 1)(Pt 1):47-60. PubMed ID: 9729616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Channel blockers acting at N-methyl-D-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore.
    Kashiwagi K; Masuko T; Nguyen CD; Kuno T; Tanaka I; Igarashi K; Williams K
    Mol Pharmacol; 2002 Mar; 61(3):533-45. PubMed ID: 11854433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease.
    Rogawski MA; Wenk GL
    CNS Drug Rev; 2003; 9(3):275-308. PubMed ID: 14530799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes.
    Buller AL; Monaghan DT
    Eur J Pharmacol; 1997 Feb; 320(1):87-94. PubMed ID: 9049607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spermine and arcaine block and permeate N-methyl-D-aspartate receptor channels.
    Araneda RC; Lan JY; Zheng X; Zukin RS; Bennett MV
    Biophys J; 1999 Jun; 76(6):2899-911. PubMed ID: 10354418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan).
    Parsons CG; Gruner R; Rozental J; Millar J; Lodge D
    Neuropharmacology; 1993 Dec; 32(12):1337-50. PubMed ID: 8152525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801.
    Rammes G; Mahal B; Putzke J; Parsons C; Spielmanns P; Pestel E; Spanagel R; Zieglgänsberger W; Schadrack J
    Neuropharmacology; 2001 May; 40(6):749-60. PubMed ID: 11369029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
    Williams K
    Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Memantine selectively blocks extrasynaptic NMDA receptors in rat substantia nigra dopamine neurons.
    Wu YN; Johnson SW
    Brain Res; 2015 Apr; 1603():1-7. PubMed ID: 25656790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine.
    Kotermanski SE; Johnson JW
    J Neurosci; 2009 Mar; 29(9):2774-9. PubMed ID: 19261873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ca2+-permeable non-NMDA glutamate receptors in rat magnocellular basal forebrain neurones.
    Waters DJ; Allen TG
    J Physiol; 1998 Apr; 508 ( Pt 2)(Pt 2):453-69. PubMed ID: 9508809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons.
    Aracava Y; Pereira EF; Maelicke A; Albuquerque EX
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1195-205. PubMed ID: 15522999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.